Ground truth for life sciences commercial teams.

You're evaluating whether to expand into a new therapeutic area. Who's active there? What tools do they use? Where are the gaps?

Generate a competitive landscape. The output shows market share by company and product, underserved segments, and where publication volume is accelerating. Drill into top researchers, examine their funding and product usage, and export the analysis for your team.

A PI's lab could become a significant account. Before the meeting, you need to understand their work.

Search for the researcher. Their profile shows recent publications, cited instruments and reagents, active grants with expiry dates, and their collaboration network. Generate a persona to understand purchasing patterns and grant renewal timing. Walk in talking about their actual work.

A new platform launch needs an audience and messaging rooted in real research challenges.

Find active researchers in your target application area, filtered by geography, institution type, and recency. A landscape analysis shows how your product category is used and where alternatives fall short. Export targeted lists and build campaigns around the applications your audience actually works with.

Should your team develop assays for a new sample type? The answer depends on what researchers are doing with it today and what tools they're combining.

Search the published literature for your target application. The results reveal which methods are gaining traction, what products appear in workflows, and where gaps exist. If researchers are publishing on a target but no commercial assay exists, that gap is quantifiable demand. Grant funding data shows where money is flowing and surfaces potential collaborators.

Leadership needs to assess whether a technology platform is worth a major investment. Evidence, not analyst opinions.

Generate a landscape for the product category. The output covers which companies have traction, how fast the field is growing, and which geographies drive demand. Grant funding, patent filings, and trial registrations reveal where investment is flowing before it converts to revenue.